Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silence Therapeutics (SLN) Other Working Capital Changes (2024 - 2025)

Silence Therapeutics' Other Working Capital Changes history spans 2 years, with the latest figure at -$5.9 million for Q4 2025.

  • For Q4 2025, Other Working Capital Changes fell 1397.45% year-over-year to -$5.9 million; the TTM value through Dec 2025 reached -$6.0 million, down 552.33%, while the annual FY2025 figure was -$6.0 million, 1413.54% down from the prior year.
  • Other Working Capital Changes for Q4 2025 was -$5.9 million at Silence Therapeutics, down from -$20000.0 in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $5.7 million in Q3 2024 and bottomed at -$5.9 million in Q4 2025.